Pfizer : PFE

All Pfizer Articles

1469 Articles

Chris Lange | Oct 30, 2016 at 10:05 AM EDT

8 Top Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Pfizer, Starbucks and some of the major companies reporting their quarterly…

Chris Lange | Oct 26, 2016 at 7:40 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Lee Jackson | Oct 24, 2016 at 8:20 AM EDT

Bad Headlines and Huge Deals Put Top Dividend Stocks on Sale

Savvy investors know that often the best time to buy a stock, especially a solid company with a mature franchise,…

Trey Thoelcke | Oct 21, 2016 at 7:45 AM EDT

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even…

Jon C. Ogg | Oct 20, 2016 at 12:25 PM EDT

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

Americans generally would like to spend less money on health care. One way that this can be and will be…

Jon C. Ogg | Oct 18, 2016 at 1:10 PM EDT

5 Dow Stocks That Analysts Grossly Overestimated for 2016

It is very rare for a year to go exactly as analysts and investors might expect. After all, predicting a…

Paul Ausick | Oct 13, 2016 at 4:01 PM EDT

Chevron, Goldman Lead DJIA Thursday Decline

October 13, 2016: Markets opened lower Thursday following a weaker view on China’s trade balance joined with worries about the…

Chris Lange | Oct 12, 2016 at 7:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Paul Ausick | Oct 6, 2016 at 4:01 PM EDT

American Express, Wal-Mart Weigh on DJIA Thursday

October 6, 2016: Markets opened slightly lower Thursday and tracked close to the break-even line for much of the day.…

Paul Ausick | Sep 29, 2016 at 4:01 PM EDT

Goldman, Merck Lead DJIA Thursday Plunge

September 29, 2016: Markets opened slightly higher again Thursday following Wednesday’s announced agreement among OPEC members to rein in production.…

Chris Lange | Sep 27, 2016 at 7:40 AM EDT

Major Pharma Continues to See Rising Tide in Short Interest

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Sep 26, 2016 at 4:01 PM EDT

Goldman Sachs, JPMorgan Sink DJIA Monday

September 26, 2016: Markets opened lower again Monday and only the recently added real-estate sector traded higher on the day.…

Chris Lange | Sep 26, 2016 at 11:10 AM EDT

Pfizer Decides Against the Split

Pfizer shares traded down marginally Monday morning after the company announced that it will abandon its plan to split into…

Lee Jackson | Sep 20, 2016 at 9:50 AM EDT

5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November

While the polls have the race pretty tight, one thing is for sure: a victory by Donald Trump would favor…

Lee Jackson | Sep 14, 2016 at 8:25 AM EDT

Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale

The volatility in the markets have shaken some of the top dividend leaders and may be giving long-term investors a…

1 … 44 45 46 47 48 … 98

Pfizer : PFE

All Pfizer Articles

8 Top Earnings for the Week Ahead

Short Sellers Grow More Selective on Major Pharma Stocks

Bad Headlines and Huge Deals Put Top Dividend Stocks on Sale

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

5 Dow Stocks That Analysts Grossly Overestimated for 2016

Chevron, Goldman Lead DJIA Thursday Decline

Major Pharma Short Sellers Grow More Selective

American Express, Wal-Mart Weigh on DJIA Thursday

Goldman, Merck Lead DJIA Thursday Plunge

Major Pharma Continues to See Rising Tide in Short Interest

Goldman Sachs, JPMorgan Sink DJIA Monday

Pfizer Decides Against the Split

5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November

Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale

If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

Gary Vee’s Warning: Start Using AI or ‘You Are Your Grandma’

SLV Is Up 132% in a Year, But Its 0.50% Fee and 28% Tax Rate Tell a Different Story

4 ETFs That Can Replace a $60,000 Salary and You Never Sell a Share

The In-Plan Roth Conversion High Earners Use to Bypass the Roth IRA Income Cap

SoundHound Stock Is Down 13% Today – Is It Outperforming Other AI Stocks Like Palantir and C3.ai?

If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

Pfizer : PFE

All Pfizer Articles

8 Top Earnings for the Week Ahead

Short Sellers Grow More Selective on Major Pharma Stocks

Bad Headlines and Huge Deals Put Top Dividend Stocks on Sale

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs

5 Dow Stocks That Analysts Grossly Overestimated for 2016

Chevron, Goldman Lead DJIA Thursday Decline

Major Pharma Short Sellers Grow More Selective

American Express, Wal-Mart Weigh on DJIA Thursday

Goldman, Merck Lead DJIA Thursday Plunge

Major Pharma Continues to See Rising Tide in Short Interest

Goldman Sachs, JPMorgan Sink DJIA Monday

Pfizer Decides Against the Split

5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November

Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale

If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

Gary Vee’s Warning: Start Using AI or ‘You Are Your Grandma’

SLV Is Up 132% in a Year, But Its 0.50% Fee and 28% Tax Rate Tell a Different Story

Featured Reads

4 ETFs That Can Replace a $60,000 Salary and You Never Sell a Share

The In-Plan Roth Conversion High Earners Use to Bypass the Roth IRA Income Cap